Image
Training slides review how neutralizing antibodies (bNAbs) develop in people with HIV, identify the potential future uses of bNAbs to prevent, treat and/or cure HIV as well as the challenges in developing bNAbs for clinical use in the context of long-acting antiretroviral therapy.
Browse more